eye problems with glp 1 GLP-1 Receptor Agonists Could Reduce Risk of Glaucoma in Type 2 Diabetes GLP-1 Treated Patients with Diabetes

Previous research by this group showed that infusing normal fetal sheep with a high dose (6.6 gkgh) of IGF-1 LR3, an analog for IGF-1, increased body weight while simultaneously reducing insulin levels and GSIS

If you think you may be deficient in B12, consider speaking with a doctor

Even a low dose can be a problem if the vial is mislabeled or contaminated

It's not just like, Oh, use it for six months, get to your goal weight, and stop. If you stop it, there's a very high chance you will regain all of the weight you lost, if not more. According to a 2022 study , most people gain back the majority of the weight they lost within one year of stopping semaglutide

reported no significant effects on BMC, BMD or bone turnover markers (such as osteocalcin, CTX, IGF-1)